Feeding Late and Moderately Preterm Infants Nutrition and Growth Outcomes (FLAMINGO)

ewcastle Hospitals NHS Foundation Trust0 sites182 target enrollmentMay 14, 2018

Overview

2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/33763438/ (added 26/03/2021) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/36183005/ (added 10/06/2024)

Registry

who.int

Start Date

May 14, 2018

End Date

May 21, 2023

Last Updated

last year

Study Type

Interventional

Sex

All

Sponsor

ewcastle Hospitals NHS Foundation Trust

•1\. Healthy moderate to late preterm infants (gestational age \= 32 and \= 36 6/7 weeks)
•2\. Age at inclusion \= term equivalent age
•3\. Birth weight between 1\.25\-2\.5 kg
•4\. Infants who are predominantly formula fed (max. 1 breastfeeding per day) using a standard term infant formula
•5\. Written informed consent from parent(s) and/or legal guardian, aged \= 18 years, to be enrolled into a randomised trial

•1\. Any gastrointestinal, congenital or other problem likely to affect growth and nutrition, or requiring use of specialised milk formula or other diet e.g. due to confirmed allergy; or where the attending medical team feel that trial participation is inappropriate for any other medical condition
•2\. Ongoing child protection procedures or maternal drug misuse requiring social services involvement
•3\. Family circumstances where follow\-up not likely to be possible e.g. family travel abroad for prolonged periods, or where it appears likely that the family will be unable to comply with the necessary research visits
•4\. Participation in another interventional study that may potentially confound or interact with this study
•5\. Family unable to understand English